Inventor
GONG YUCHUAN
US20 patents
⚠️ This page may combine multiple inventors who share the name “GONG YUCHUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
8 patentsUS9321765B2Apr 26, 2016
Crystalline bromodomain inhibitors
ABBVIE INC18 citations92
US9637476B2May 2, 2017
Atrasentan mandelate salts
ABBVIE INC8 citations83
US8962675B1Feb 24, 2015
Atrasentan mandelate salts
ABBVIE INC13 citations83
US10730873B2Aug 4, 2020
Salts and crystalline forms of an apoptosis-inducing agent
ABBVIE INC1 citations72
US9840502B2Dec 12, 2017
Salts and crystalline forms of an apoptosis-inducing agent
ABBVIE INC2 citations72
US9238649B2Jan 19, 2016
Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
ABBVIE INC3 citations72
US9469673B2Oct 18, 2016
Crystaline forms of HCV inhibitor
ABBVIE INC4 citations68
US12083227B2Sep 10, 2024
Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
ABBVIE INC0 citations51
VERTEX PHARMA
6 patentsUS8754224B2Jun 17, 2014
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
VERTEX PHARMA97 citations98
US9931334B2Apr 3, 2018
Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
VERTEX PHARMA35 citations97
US9670163B2Jun 6, 2017
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
VERTEX PHARMA44 citations97
US9139530B2Sep 22, 2015
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
VERTEX PHARMA64 citations97
US10537565B2Jan 21, 2020
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
VERTEX PHARMA24 citations94
US11291662B2Apr 5, 2022
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
VERTEX PHARMA5 citations84
CELGENE CORP
2 patentsUS12220417B2Feb 11, 2025
Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same
CELGENE CORP0 citations56
US11504378B2Nov 22, 2022
Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same
CELGENE CORP0 citations56